Prevalence and Prescription of Antidepressants in Depression with Somatic Comorbidity in Asia: The Research on East Asian Psychotropic Prescription Patterns Study
暂无分享,去创建一个
T. Si | K. Sim | E. Kua | N. Sartorius | G. Ungvari | Y. Xiang | J. Trivedi | N. Shinfuku | Chay-Hoon Tan | E. Chung | K. Chee | S. Fujii | P. Udomratn | Yan-ling He | Chao Chen | Chuanyue Wang
[1] A. Clayton,et al. Sexual dysfunction associated with major depressive disorder and antidepressant treatment , 2014, Expert opinion on drug safety.
[2] Libo Zhao,et al. Prevalence, correlates and recognition of depression in Chinese inpatients with cancer. , 2014, General hospital psychiatry.
[3] C. Browning,et al. Prevalence of depression in coronary heart disease in China: a systematic review and meta‐analysis , 2014, Chinese medical journal.
[4] S. Kennedy,et al. Treatment-Resistant Depression in Primary Care Across Canada , 2014, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[5] J. Ruskin,et al. Meta-analysis of selective serotonin reuptake inhibitor-associated QTc prolongation. , 2014, The Journal of clinical psychiatry.
[6] Olga Hilas,et al. Potential role of mirtazapine in underweight older adults. , 2014, The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists.
[7] D. Miličić,et al. Somatic comorbidity, metabolic syndrome, cardiovascular risk, and CRP in patients with recurrent depressive disorders , 2013, Croatian medical journal.
[8] H. Möller,et al. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders , 2013, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
[9] B. Penninx,et al. The Impact of Chronic Somatic Diseases on the Course of Depressive and Anxiety Disorders , 2012, Psychotherapy and Psychosomatics.
[10] Jens Knud Larsen. Mirtazapine versus other antidepressive agents for depression , 2012, Ugeskrift for laeger.
[11] Gert P. Westert,et al. Current Guidelines Have Limited Applicability to Patients with Comorbid Conditions: A Systematic Analysis of Evidence-Based Guidelines , 2011, PloS one.
[12] From Ora Staff Reports. FDA Safety Alert: Abnormal heart rhythms associated with high doses of citalopram hydrobromide , 2011 .
[13] B. Zhong,et al. Prevalence, correlates and recognition of depression among inpatients of general hospitals in Wuhan, China. , 2010, General hospital psychiatry.
[14] Qichang Shi,et al. Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001–05: an epidemiological survey , 2009, The Lancet.
[15] W. Eaton,et al. Depression and Type 2 Diabetes Over the Lifespan: A Meta-Analysis , 2009, Diabetes Care.
[16] R. Kessler,et al. Association of perceived stigma and mood and anxiety disorders: results from the World Mental Health Surveys , 2008, Acta psychiatrica Scandinavica.
[17] M. Phillips,et al. Prevalence and rates of recognition of depressive disorders in internal medicine outpatient departments of 23 general hospitals in Shenyang, China. , 2008, Journal of affective disorders.
[18] L. Turhan,et al. Mirtazapine improves sleep and lowers anxiety and depression in cancer patients: superiority over imipramine , 2008, Supportive Care in Cancer.
[19] P. Groenewegen,et al. The influence of specific chronic somatic conditions on the care for co-morbid depression in general practice , 2007, Psychological Medicine.
[20] D. Rao,et al. Culture, Somatization, and Psychological Distress: Symptom Presentation in South Indian Patients from a Public Psychiatric Hospital , 2007, Psychopathology.
[21] H. V. van Hout,et al. Depression and the risk for cardiovascular diseases: systematic review and meta analysis , 2007, International journal of geriatric psychiatry.
[22] R. Baldessarini,et al. Newer antidepressant drug use in East Asian psychiatric treatment settings: REAP (Research on East Asia Psychotropic Prescriptions) Study. , 2007, British journal of clinical pharmacology.
[23] A. Rush. STAR*D: what have we learned? , 2007, The American journal of psychiatry.
[24] D. Steffens,et al. A three‐factor analytic model of the MADRS in geriatric depression , 2003, International journal of geriatric psychiatry.
[25] B. Mulsant,et al. Post stroke depression: epidemiology, pathophysiology, and biological treatment , 2002, Biological Psychiatry.
[26] K. Freedland,et al. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. , 2001, Diabetes care.
[27] John E. Roberts,et al. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. , 2001, The American journal of psychiatry.
[28] S. Patten,et al. Long-term medical conditions and major depression in a Canadian population study at waves 1 and 2. , 2001, Journal of affective disorders.
[29] C. Murray,et al. Burden of disease--implications for future research. , 2001, JAMA.
[30] R. Carney,et al. Depression as a risk factor for cardiac events in established coronary heart disease: A review of possible mechanisms , 1995, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.
[31] A. Stewart,et al. The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. , 1989, JAMA.
[32] Xu Jiong-jion. Choice of First-visit Modes of Patients with Depressive Disorders and Its Clinical Characteristics , 2012 .
[33] K. Otani,et al. A three‐factor model of the MADRS in major depressive disorder , 2005, Depression and anxiety.
[34] Matthew J. Taylor,et al. Strategies for managing sexual dysfunction induced by antidepressant medication. , 2004, The Cochrane database of systematic reviews.
[35] I. Levav,et al. The WHO World Health Report 2001 new understanding--new hope. , 2002, The Israel journal of psychiatry and related sciences.